BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31168337)

  • 1. Scenario and future prospects of microRNAs in gastric cancer: A review.
    Bhat SA; Majid S; Rehman MU
    Iran J Basic Med Sci; 2019 Apr; 22(4):345-352. PubMed ID: 31168337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
    Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
    Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.
    Wu HH; Lin WC; Tsai KW
    Expert Rev Mol Med; 2014 Jan; 16():e1. PubMed ID: 24456939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as diagnostic biomarkers in gastric cancer.
    Yin Y; Li J; Chen S; Zhou T; Si J
    Int J Mol Sci; 2012 Oct; 13(10):12544-55. PubMed ID: 23202912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
    Shekari N; Baradaran B; Shanehbandi D; Kazemi T
    Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of microRNAs in gastric cancer.
    Ishiguro H; Kimura M; Takeyama H
    World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer.
    Yuan HL; Wang T; Zhang KH
    Onco Targets Ther; 2018; 11():3891-3900. PubMed ID: 30013369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment.
    Mirzajani E; Vahidi S; Norollahi SE; Samadani AA
    Microrna; 2022; 11(1):12-24. PubMed ID: 35319404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.
    Liu Y; Ao X; Wang Y; Li X; Wang J
    Front Oncol; 2022; 12():841411. PubMed ID: 35155266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening.
    Wang H; Wang L; Wu Z; Sun R; Jin H; Ma J; Liu L; Ling R; Yi J; Wang L; Bian J; Chen J; Li N; Yuan S; Yun J
    Med Oncol; 2014 Dec; 31(12):298. PubMed ID: 25367852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
    Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
    World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.
    Jiang C; Chen X; Alattar M; Wei J; Liu H
    Cancer Gene Ther; 2015 Jun; 22(6):291-301. PubMed ID: 25998522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as promising biomarkers for gastric cancer.
    Wang F; Sun GP; Zou YF; Hao JQ; Zhong F; Ren WJ
    Cancer Biomark; 2012; 11(6):259-67. PubMed ID: 23248184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
    Ahadi A
    Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications.
    Chen D; Ping S; Xu Y; Wang M; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
    Front Cell Dev Biol; 2021; 9():732036. PubMed ID: 34805143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.